SQUAMOUS CELL CARCINOMA OF THE TONGUE

FAZ: participated in the care of the patient and wrote the article. SO:participated in the care of the patient. SB: participated in the writing ofarticle. MR and LG: realized the histopathologic analysis. HM: participated inthe writing <[r]

cells. Nat Cell Biol2007, 9:625-635.22. Nishimoto M, Miyagi S, Katayanagi T, Tomioka M, Muramatsu M, Okuda A:The embryonic Octamer factor 3/4 displays distinct DNA bindingspecificity from those of other Octamer factors. Biochem Biophys ResCommun 2003, 302:581-586.23. Thompson L:[r]

UNG THƯ TẾ BÀO VẢY (Squamous Cell Carcinoma) Ung thư tế bào vảy thường gặp thứ hai trong ung thư da sau ung thư tế bào đáy. Dịch tễ học Tần số: tỷ lệ mắc bệnh SCC rất khác nhau giữa các nước. Australia là một trong những nước có tỷ lệ mắc bệnh cao nhất 1.332 ca/100.000 dân đối v[r]

Modified docetaxel, cisplatin, and 5-fluorouracil (mDCF) regimen has become a new standard for the treatment of metastatic or unresectable locally advanced recurrent squamous cell carcinoma of the anus (SCCA) after demonstrating improved efficacy (12-month PFS of 47%) in the Epitopes-HPV02 trial.

patients with esophageal squamous cell carcinoma. Cancer Sci 2006,97:380-6.10. Fujita Y, Nakanishi T, Miyamoto Y, Hiramatsu M, Mabuchi H, Miyamoto A,Shimizu A, Takubo T, Tanigawa N: Proteomics-based identification ofautoantibody against heat shock protein 70 as a diagnostic mark[r]

The gene encoding fibroblast growth factor receptor 1 (FGFR1) is emerging as a therapeutic and prognostic biomarker in various cancer types, including head and neck squamous cell carcinoma (SCC).

Neoadjuvant therapy plus oesophagectomy has been accepted as the standard treatment for patients with potentially curable locally advanced oesophageal cancer. No completed randomized controlled trial (RCT) has directly compared neoadjuvant chemotherapy and neoadjuvant chemoradiation in patients with[r]

revised it critically. All authors read and approved the final manuscript.Competing interestsThe authors declare that they have no competing interests.Received: 27 December 2010 Accepted: 23 March 2011Published: 23 March 2011References1. Greenlee RT, Hill-Harmon MB, Murray T, Thun M: Cancer s[r]

growth factor receptor blockade in squamous cell carcinomas: inhibitionof damage repair, cell cycle kinetics, and tumor angiogenesis. Clin CancerRes 2000, 6:2166-2174.36. Nyati MK, Morgan MA, Feng FY, Lawrence TS: Integration of EGFRinhibitors with radiochemotherapy. Nat[r]

prognosis in comparison with those who had reduced or absent expression levels. Using over-expression andknockdown approach, we created sublines from ESCC cells and further demonstrated that MTSS1 expression inESCC cells significantly influenced the aggressiveness of the oesopha[r]

1. School of Pharmacy and Pharmaceutical Sciences, Mukogawa Women’s University, Nishinomiya, Japan; 2. Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan; 3. Kobe University Graduate School of Medicine, Kobe, Japan; 4. Faculty of Pharmaceutical Sci[r]

prognosis in comparison with those who had reduced or absent expression levels. Using over-expression andknockdown approach, we created sublines from ESCC cells and further demonstrated that MTSS1 expression inESCC cells significantly influenced the aggressiveness of the oesopha[r]

National Cancer Institute 73 SEER Survival Monograph INTRODUCTIONThis study provides survival analyses for 201,067 histo-logically confirmed adult cases of lung cancer diagnosed from 1988 through 2001. Cases were obtained from the Surveillance, Epidemiology, and End Results (SEER) Prog[r]

Chapter 087. Gastrointestinal Tract Cancer (Part 2) Clinical Features About 10% of esophageal cancers occur in the upper third of the esophagus (cervical esophagus), 35% in the middle third, and 55% in the lower third. Squamous cell carcinomas[r]

strategies include the use of purified tumor proteins as immunogens and the use of genetically altered tumor cells to elicit a T cell response. Alternative experimental approaches include efforts to expand tumor-specific T cells (either obtained from the tum[r]

Ung Thư Thanh Quản Bệnh nhân 69 tuổi (khi khám bệnh năm 2003) than phiền bị khan tiếng vài tháng. Bệnh nhân uống trụ sinh (vì nghĩ bệnh nhân bị viêm nhiễm trùng cổ họng) nhưng không hết. Chuyển bệnh nhân sang bác sĩ chuyên khoa tai mũi họng. Bác sĩ tai mũi họng khám bệnh cho thấy tai bệnh nhân b[r]

Chapter 087. Gastrointestinal Tract Cancer (Part 16) Cancers of the Anus Cancers of the anus account for 1–2% of the malignant tumors of the large bowel. Most such lesions arise in the anal canal, the anatomic area extending from[r]

We investigated whether head and neck squamous cell carcinoma (HNSCC) patient-derived xenografts (PDXs) reaffirm patient responses to anti-cancer therapeutics.

in vitro and in vivo studies have demonstrated the anti-tumor ef-fects of curcumin on OSCC as a single agent as well as in combina-tion with currently available conventional therapies. It should benoted that the in vitro studies are actually a mixture of oral andoropharyngeal